IL1B and psoriasis: [16] In psoriasis, the subcutaneous injection of recombinant CD200 protein in imiquimod-induced psoriasis like inflammation in mice skin resulted in symptom attenuation, and reduction of serum levels of the pro-inflammatory mediators IL-6, IL-1β, and TNF-α.